|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
7
|
|
pubmed:dateCreated |
1996-8-5
|
|
pubmed:abstractText |
This study evaluated the toxicity of high-dose epirubicin and cyclophosphamide plus r-met-HUG-CSF (G-CSF) given every 2 weeks and compared the dose-intensity achieved with this schedule with that obtained in a previous study we conducted in which the same regimen was given every 3 weeks without G-SCF (EC 21). The secondary objective was to explore the activity of this regimen.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Sep
|
|
pubmed:issn |
0923-7534
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
6
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
665-71
|
|
pubmed:dateRevised |
2011-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:8664187-Adult,
pubmed-meshheading:8664187-Aged,
pubmed-meshheading:8664187-Antibiotics, Antineoplastic,
pubmed-meshheading:8664187-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:8664187-Breast Neoplasms,
pubmed-meshheading:8664187-Cyclophosphamide,
pubmed-meshheading:8664187-Epirubicin,
pubmed-meshheading:8664187-Female,
pubmed-meshheading:8664187-Granulocyte Colony-Stimulating Factor,
pubmed-meshheading:8664187-Humans,
pubmed-meshheading:8664187-Middle Aged,
pubmed-meshheading:8664187-Neoplasm Metastasis,
pubmed-meshheading:8664187-Neutropenia,
pubmed-meshheading:8664187-Recombinant Proteins,
pubmed-meshheading:8664187-Remission Induction
|
|
pubmed:year |
1995
|
|
pubmed:articleTitle |
Accelerated chemotherapy with high-dose epirubicin and cyclophosphamide plus r-met-HUG-CSF in locally advanced and metastatic breast cancer.
|
|
pubmed:affiliation |
Servizio di Oncologia Medica, Istituto Regina Elena per lo Studio e la Cura dei Tumori, Rome, Italy.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Research Support, Non-U.S. Gov't,
Clinical Trial, Phase II
|
